Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Loading Protocols for Dental Implants Placed in Healed Fully Edentulous Maxilla

perjantai 1. toukokuuta 2026 päivittänyt: Aleksa Markovic, University of Belgrade

Immediate Vs Early Loading Protocols in Rehabilitation of Healed Fully Edentulous Maxilla

The goal of this clinical trial is to compare immediate versus early loading protocols for complete implant-supported fixed dental prostheses in healed edentulous maxillae.

The main questions it aims to answer are:

  • How does the timing of delivery of the prosthesis affect the stability of the implant and the surrounding soft and bone tissue?
  • Does prosthesis delivery time affect quality of life and patient satisfaction? Researchers will compare immediate and early (6 weeks after implant placement) loading protocols in rehabilitation of fully edentulous upper jaw.

Participants will:

  • Receive 6 dental implants in the edentulous upper jaw and after that complete fixed dental prostheses will be delivered immediately or 6 weeks after implant placement.
  • Visit the clinic at the scheduled time for checkups and tests

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

Surgical protocol Prior to surgery antibiotic prophylaxis (2 g amoxicillin with clavulonic acid or, in case of allergy, 0.6 g clindamycin, 1 hour before the procedure) and antiedema therapy (0.004 g dexamethasone 1 hour before the procedure) was administered. Patients rinsed their mouth using 15 mL of 0.12% chlorhexidine solution for 1 minute preoperatively. The surgical procedures were performed under local anesthesia using 4% articaine, 1:100.000 epinephrine. Centers of the intended implant sites were marked according to the reference marks present in the patient's existing complete removable denture that had been used as the radiographic stent. A midcrestal incision was made, then full-thickness buccal and palatal flaps were elevated. Implant sites were prepared by strictly adhering to the manufacturer's protocol for low-density bone using drills of increasing diameter (Institut Straumann). To provide adequate primary implant stability, underpreparation was performed: 1. In low-density type D3 bone, the profile drill was skipped; and 2. In low-density type D4 bone, the final sequence and profile drills were skipped. Intermittent drilling under copious irrigation was performed with low hand pressure and a physiodispenser running between 600 and 800 rpm. A total of 144 sites were prepared, followed by placement of 144 SLActive surface (Bone Level Tapered, Institut Straumann) implants. Bone quality was assessed according to the Lekholm and Zarb classification. In sites with dehiscence or fenestration resulting in an exposed implant surface, localized bone augmentation was performed using bovine-derived xenograft (Geistlich Bio-Oss, Geistlich, Wolhusen, Switzerland) and covered with a type 1 collagen membrane (Geistlich Bio-Gide, Geistlich). Healing screws (Institut Straumann; NC healing abutment Ø4.8 mm conical 5 mm and RC healing abutment Ø5 mm conical 6 mm) were placed and primary wound closure was achieved with 5-0 single resorbable sutures (AssuCryl Lactin, Assut Sutures of Switzerland, Pully-Lausanne, Switzerland). Patients were discharged with recommendations regarding dietetic and hygienic regimens. Antibiotic protocol consisted of 2 g amoxicillin with clavulonic acid (divided into 2 doses) or, in case of allergy, 1.8 g clindamycin daily (divided into 3 doses) for the following 5 days. Antiedema therapy (0.004 g dexamethasone) was administered 24 hours postoperatively. Prosthetic protocol After dental implant placement, patients were randomly assigned to immediate loading or early loading groups.

Implants for patients from Test Group were immediately loaded using S-R abutments (Institut Straumann) with temporary restorations. Patients from Control Group did not receive any kind of prosthetic temporization and were left with healing abutments. For Test Group an open-tray impression technique was used for provisional restoration. Impressions were made using: ASilicone material (Hydrorise implant, Zhermack, Badia Polesine, Italy), splinted impression posts (RC and NC impression post, Straumann) and a plastic impression tray (Miratray, Hager Werken, Duisburg, Germany). Provisional restorations were made digitally with polymethyl methacrylate (PMMA) (Telio CAD, Ivoclar Vivadent, Schaan, Lichtenstein). Plaster models with scan bodies were digitized with a laboratory scanner (3Shape E1, 3Shape, Copenhagen, Denmark). Final virtual design of provisional restoration was performed with 3D design software (exocad Matera 2.3, Exocad, Darmstadt, Germany). Drilling of PMMA blocks was performed in a 5-axis milling machine (Zenotec Select, Wieland, Pforzheim, Germany). The following final Straumann screw retained abutments for the prosthetic bridge (Institut Straumann) were chosen according to implant angulation and surrounding soft tissue height. For the interface between the screw-retained abutments and final prosthetic work, copings for screw retained abutments (Institut Straumann) were used and bonded to the final prosthesis.

At the end of the 6-week healing period for both groups, definitive prosthetic restorations were delivered. In preparation for the definitive prosthesis, a final open-tray impression was taken with an individual tray and polyether material (Impregum Soft, 3M Espe, Seefeld, Germany). An analog ceramic layering technique was performed in the process of producing a porcelain fused to metal restoration (Shofu Vintage Halo Porcelain, Shofu Dental Corporation, Ratingen, Germany). The metal framework was made using cobalt chromium metal powder material (Starbond Easy Powder 45, Scheftner, Mainz, Germany) with additive manufacturing technologies (EOS, Krailling, Germany).

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

24

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

      • Belgrade, Serbia, 11000
        • Implant Center, School of Dental Medicine, University of Belgrade

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Joo

Kuvaus

Inclusion Criteria:

  1. Patients in good general health with no current history of systemic disease or medication use that could interfere with the treatment;
  2. Patients with complete maxillary edentulism who had lost their teeth at least 6 to 8 weeks prior to the proposed ''allon- six'' implant rehabilitation; and
  3. Clinically compliant patients consenting to be enrolled into the study.

Exclusion Criteria:

  1. Active or chronic disease that affects bone metabolism or wound healing;
  2. Diminished mental capacities that could mitigate the ability to comply with the protocol;
  3. Residual roots or teeth;
  4. History of maxillary augmentation;
  5. Oral carcinoma or inflammatory changes; and
  6. History of head and neck radiotherapy.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Immediately loading
Implants will be loaded with temporary prosthesis immediatelly after their insertion
Implants will be immediately loaded using S-R abutments (Institut Straumann) with temporary restorations. An open-tray impression technique was used for provisional restoration. Provisional restorations were made digitally with polymethyl methacrylate (PMMA) (Telio CAD, Ivoclar Vivadent, Schaan, Lichtenstein). Plaster models with scan bodies were digitized with a laboratory scanner (3Shape E1, 3Shape, Copenhagen, Denmark). Final virtual design of provisional restoration was performed with 3D design software (exocad Matera 2.3, Exocad, Darmstadt, Germany). Drilling of PMMA blocks was performed in a 5-axis milling machine (Zenotec Select, Wieland, Pforzheim, Germany). After 6 weeks they will receive final prosthesis.
Muut nimet:
  • Testiryhmä
Active Comparator: Early loading
Implants will be left to heal with healing abutments for 6 weeks without prosthesis
At the end of the 6-week healing period, definitive prosthetic restorations were delivered. In preparation for the definitive prosthesis, a final open-tray impression was taken with an individual tray and polyether material (Impregum Soft, 3M Espe, Seefeld, Germany). An analog ceramic layering technique was performed in the process of producing a porcelain fused to metal restoration (Shofu Vintage Halo Porcelain, Shofu Dental Corporation, Ratingen, Germany). The metal framework was made using cobalt chromium metal powder material (Starbond Easy Powder 45, Scheftner, Mainz, Germany) with additive manufacturing technologies (EOS, Krailling, Germany).
Muut nimet:
  • Kontrolliryhmä

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Implant stability
Aikaikkuna: Implant stability will be measured at the time of implant placement (baseline) and at post-op week 6 (prior to delivery of definitive prosthetic restoration) and then after 5, 10 and 15 years
Implant stability will be recorded by Osstell Mentor and Penguin using Resonance frequency analysis (RFA) method. Results were recorded on an implant stability scale (ISQ) from 1 to 100. The higher the ISQ, the more stable the implant was.21 Two consecutive measurements delivering the same ISQ values were considered authentic.
Implant stability will be measured at the time of implant placement (baseline) and at post-op week 6 (prior to delivery of definitive prosthetic restoration) and then after 5, 10 and 15 years

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Insertion torque
Aikaikkuna: During surgery, at implant placement in prepared implant site.
Insertion torque was measured with a torque wrench (Institut Straumann) and recorded in Ncm.
During surgery, at implant placement in prepared implant site.
Marginal bone loss change from baseline to 5,10 and 15 years follow up
Aikaikkuna: At final prosthesis delivery (baseline), after 5,10 and 15 years follow up
Following prosthesis and multiunit abutment removal, standardized healing abutments (identical to baseline protocol) were placed. CBCT images were acquired at the same exposure parameters as baseline and analyzed by one blinded examiner using OnDemand3D software (Cybermed Inc., Seoul, South Korea). MBL was measured as the linear distance from the implant shoulder to first bone-implant contact at four sites per implant: mesial, distal, buccal, and palatal aspects.
At final prosthesis delivery (baseline), after 5,10 and 15 years follow up
Changes in Buccal Plate thickness from baseline to 5,10 and 15 years follow up
Aikaikkuna: At final prosthesis delivery (baseline) to 5,10 and 15 years follow up
Following prosthesis and multiunit abutment removal, standardized healing abutments (identical to baseline protocol) were placed. CBCT images were acquired at the same exposure parameters as baseline and analyzed by one blinded examiner using OnDemand3D software (Cybermed Inc., Seoul, South Korea). BPT was measured perpendicular to the implant axis at two locations: 2 mm apical to the implant-abutment connection and at implant midlength.
At final prosthesis delivery (baseline) to 5,10 and 15 years follow up
Oral health-related quality of life
Aikaikkuna: At implant placement (baseline), 1 month after definitive prosthesis delivery, and after 5,10 and 15 years
Oral health-related quality of life was evaluated using the OHIP-19 questionnaire. It consists of 19 questions and patients rated each item on a 5-point scale, where 0 indicated "never" and 4 indicated "constantly." The total OHIP-19 score was obtained by summing the scores from all questions. Lower score meant improved quality of life.
At implant placement (baseline), 1 month after definitive prosthesis delivery, and after 5,10 and 15 years
Patient satisfaction
Aikaikkuna: At implant placement (baseline), 1 month after final prosthesis delivery and after 5,10 and 15 years follow up.
Patients specified their level of satisfaction related to function, esthetics, and discomfort/pain by indicating a position along a 10-cm line between 2 endpoints where the beginning of the line was marked as complete unsatisfaction and the end as maximum satisfaction on Visual Analogue Scale.
At implant placement (baseline), 1 month after final prosthesis delivery and after 5,10 and 15 years follow up.
Implant survival rate
Aikaikkuna: 1 month after final prosthesis delivery, after 5, 10 and 15 years follow up
Implant survival was defined as implant in situ regardless of condition or peri-implant disease presence.
1 month after final prosthesis delivery, after 5, 10 and 15 years follow up
Prosthesis survival rate
Aikaikkuna: 1 month after final prosthesis delivery, after 5, 10 and 15 years follow up
Prosthesis survival was defined as original prosthesis in function with or without minor repairs.
1 month after final prosthesis delivery, after 5, 10 and 15 years follow up
Complications
Aikaikkuna: 1 month after final prosthesis delivery, after 5, 10 and 15 years follow up
Biological complications (implant failure requiring removal, peri-implantitis, peri-implant mucositis) and mechanical complications (prosthesis fracture, veneer chipping, screw loosening/fracture, abutment complications) were recorded.
1 month after final prosthesis delivery, after 5, 10 and 15 years follow up

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Perjantai 1. maaliskuuta 2019

Ensisijainen valmistuminen (Arvioitu)

Torstai 1. maaliskuuta 2035

Opintojen valmistuminen (Arvioitu)

Torstai 1. maaliskuuta 2035

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 1. toukokuuta 2026

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Perjantai 1. toukokuuta 2026

Ensimmäinen Lähetetty (Todellinen)

Torstai 7. toukokuuta 2026

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Torstai 7. toukokuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Perjantai 1. toukokuuta 2026

Viimeksi vahvistettu

Perjantai 1. toukokuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

JOO

IPD-suunnitelman kuvaus

1 month, 5 years, 10 years and 15 years outcomes will be published in the journal.

IPD-jaon aikakehys

2022-2036

IPD-jaon käyttöoikeuskriteerit

The investigators will share analyzed outcomes, surgical and prosthetic protocols.

IPD-jakamista tukeva tietotyyppi

  • STUDY_PROTOCOL
  • MAHLA
  • ICF

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa